Evaluation of exposure of regorafenib and its metabolites in cancer patients with renal impairment by modelling, simulation, and clinical study
Block, M., Ploeger, B., Grevel, J., Schnizler, K., Gerisch, M., Hafner, F.-T., Reschke, S., Huang, F., Trnkova, Z.J., Sturm, I., Cleton, A.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Evaluation of exposure of regorafenib (REG) and its metabolites in pediatric patients by modeling, simulation, and clinical study
Ploeger, B., Grevel, J., Frede, M., Block, M., Schnizler, K., Gerisch, M., Hafner, F.-T., Trnkova, Z.J., Agostinho, A.C., Sturm, I., Cleton, A.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Noncompetitive Immunoassay of Small Analytes at the Femtomolar Level by Affinity Probe Capillary Electrophoresis: Direct Analysis of Digoxin Using a Uniform-Labeled scFv Immunoreagent
Hafner, Frank T, Kautz, Roger A, Iverson, Brent L, Tim, Roger C, Karger, Barry L
Published in Analytical chemistry (Washington) (01.12.2000)
Published in Analytical chemistry (Washington) (01.12.2000)
Get full text
Journal Article
Dibenzodioxocinones—A new class of CETP inhibitors
Brückner, David, Hafner, Frank-Thorsten, Li, Volkhart, Schmeck, Carsten, Telser, Joachim, Vakalopoulos, Alexandros, Wirtz, Gabriele
Published in Bioorganic & medicinal chemistry letters (01.08.2005)
Published in Bioorganic & medicinal chemistry letters (01.08.2005)
Get full text
Journal Article